Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial Metrics

Biocon gets USFDA nod for antifungal medication Micafungin

Written By Ruchika Sharma4 Jun 2024 2:51 PM IST

Bengaluru: Biocon Limited has received approval from the U.S. Food and Drug Administration (US FDA), for its vertically integrated, complex...

Dr. Reddys Labs Bags Health Canada Nod for Ozempic Generic, OneSource to Scale Supply

Dr Reddy's Labs arm Aurigene Pharma inaugurates biologics facility in Genome Valley

Written By Ruchika Sharma4 Jun 2024 11:55 AM IST

Hyderabad: Aurigene Pharmaceutical Services Limited, a Dr Reddy's Laboratories Limited company, inaugurated its biologics facility spread across...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK disagrees with ruling by Delaware State Court on ranitidine litigation, to seek appeal

Written By Ruchika Sharma3 Jun 2024 2:41 PM IST

London: GSK plc has announced that it disagrees with the ruling by the Delaware State Court and will immediately seek an appeal. The decision by...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Lupin bags USFDA tentative nod for Letermovir Tablets

Written By Ruchika Sharma3 Jun 2024 1:30 PM IST

Mumbai: Global pharma major Lupin Limited today announced that the Company has received a tentative approval from the United States Food and Drug...

Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

Aurobindo Pharma unit partners with MSD to foray into contract manufacturing operations

Written By Ruchika Sharma3 Jun 2024 12:42 PM IST

Hyderabad: Drug firm, Aurobindo Pharma has said that TheraNym Biologics, a wholly-owned subsidiary of the Company and an affiliate of...

Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag International

Johnson & Johnson concludes acquisition of Shockwave Medical

Written By Ruchika Sharma2 Jun 2024 3:31 PM IST

New Brunswick: Johnson & Johnson has announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson &...

Moderna gets USFDA nod for mRNA RSV vaccine

Written By Ruchika Sharma2 Jun 2024 1:30 PM IST

Cambridge: Moderna, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

Sanofi concludes acquisition of Inhibrx

Written By Ruchika Sharma2 Jun 2024 11:00 AM IST

Paris: Sanofi has announced the completion of its acquisition of Inhibrx, Inc. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s...

Sanofi India appoints Haresh Vala as Company Secretary, Compliance Officer

Sanofi-Regeneron Dupixent recommended for EU approval by CHMP to treat COPD patients

Written By Ruchika Sharma1 Jun 2024 3:33 PM IST

Paris: Sanofi and Regeneron have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma

Written By Ruchika Sharma1 Jun 2024 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal

Results of Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024

Written By Ruchika Sharma1 Jun 2024 11:30 AM IST

Mumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced that the primary results of the Nidlegy Phase III PIVOTAL...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

USFDA requests additional data on Sanofi Dupixent for treating smoker's lung

Written By Ruchika Sharma31 May 2024 3:16 PM IST

Paris: Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) requested additional efficacy analyses on the efficacy...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok